Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Allogeneic transplantation provides added benefit to FMS‐like tyrosine kinase 3 (FLT3) inhibitors for both low‐intensity and high‐intensity regimens in FLT3‐mutated acute myeloid leukemia

Cancer(2025)10.1002/cncr.35973Source: DataRank Database

Allogeneic transplantation provides added benefit to FMS‐like tyrosine kinase 3 (FLT3) inhibitors for both low‐intensity and high‐intensity regimens in FLT3‐mutated acute myeloid leukemia is a research paper published in Cancer (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: bronzeTopics (20)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Pamela S. Becker ORCID

Live enrichment

PubMed:40652363 OpenAlex:https://openalex.org/W4412371849

National Institutes of Health, Grant/Award Number

Grant: RC2 DK 127989

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35973

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35973

publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.35973

journalhttps://doi.org/10.1002/cncr.35973

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40652363

Fields of Study

Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia research

Keywords

MedicineMyeloid leukemiaFms-Like Tyrosine Kinase 3OncologyTyrosine kinaseTransplantationTyrosine-kinase inhibitorInternal medicineMyeloidLeukemiaCancerMutationChemotherapyAcute myeloid leukemiaAllogeneic Hematopoietic Cell TransplantationTargeted InhibitorFms‐like Tyrosine Kinase 3 (Flt3)

Sustainable Development Goals

SDG 0: Good health and well-being